These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

311 related items for PubMed ID: 18053228

  • 1. Aspects of statin prescribing in Norwegian counties with high, average and low statin consumption - an individual-level prescription database study.
    Hartz I, Sakshaug S, Furu K, Engeland A, Eggen AE, Njølstad I, Skurtveit S.
    BMC Clin Pharmacol; 2007 Dec 05; 7():14. PubMed ID: 18053228
    [Abstract] [Full Text] [Related]

  • 2. Statin prescribing in the elderly in the Netherlands: a pharmacy database time trend study.
    Geleedst-De Vooght M, Maitland-van der Zee AH, Schalekamp T, Mantel-Teeuwisse A, Jansen P.
    Drugs Aging; 2010 Jul 01; 27(7):589-96. PubMed ID: 20583852
    [Abstract] [Full Text] [Related]

  • 3. Cholesterol level goal attainment with statins: clinical management guideline recommendations versus management in actual clinical practice.
    Heintjes EM, Penning-van Beest FJ, Plat AW, Meerding WJ, Webb K, Sturkenboom MC, Herings RM.
    Pharmacotherapy; 2012 Jul 01; 32(7):631-41. PubMed ID: 22760692
    [Abstract] [Full Text] [Related]

  • 4. Switching statins in Norway after new reimbursement policy: a nationwide prescription study.
    Sakshaug S, Furu K, Karlstad Ø, Rønning M, Skurtveit S.
    Br J Clin Pharmacol; 2007 Oct 01; 64(4):476-81. PubMed ID: 17441934
    [Abstract] [Full Text] [Related]

  • 5. Co-administration of statins with cytochrome P450 3A4 inhibitors in a UK primary care population.
    Bakhai A, Rigney U, Hollis S, Emmas C.
    Pharmacoepidemiol Drug Saf; 2012 May 01; 21(5):485-93. PubMed ID: 22237927
    [Abstract] [Full Text] [Related]

  • 6. Low-density lipoprotein cholesterol (LDL-C) levels and LDL-C goal attainment among elderly patients treated with rosuvastatin compared with other statins in routine clinical practice.
    Harley CR, Gandhi S, Blasetto J, Heien H, Sasane R, Nelson SP.
    Am J Geriatr Pharmacother; 2007 Sep 01; 5(3):185-94. PubMed ID: 17996658
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Co-medication of statins and CYP3A4 inhibitors before and after introduction of new reimbursement policy.
    Devold HM, Molden E, Skurtveit S, Furu K.
    Br J Clin Pharmacol; 2009 Feb 01; 67(2):234-41. PubMed ID: 19220274
    [Abstract] [Full Text] [Related]

  • 10. Cardiovascular outcomes among patients newly initiating atorvastatin or simvastatin therapy: a large database analysis of managed care plans in the United States.
    Foody JM, Joyce AT, Rudolph AE, Liu LZ, Benner JS.
    Clin Ther; 2008 Jan 01; 30(1):195-205. PubMed ID: 18343257
    [Abstract] [Full Text] [Related]

  • 11. Achievement of LDL-cholesterol goal with statins after an st segment elevation myocardial infarction.
    Tungsubutra W, Phongtuntakul B.
    J Med Assoc Thai; 2015 Feb 01; 98(2):129-36. PubMed ID: 25842792
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Differences between statins on clinical endpoints: a population-based cohort study.
    Dieleman JP, van Wyk JT, van Wijk MA, van Herpen G, Straus SM, Dunselman H, Sturkenboom MC.
    Curr Med Res Opin; 2005 Sep 01; 21(9):1461-8. PubMed ID: 16197665
    [Abstract] [Full Text] [Related]

  • 15. Persistence of atorvastatin and simvastatin among patients with and without prior cardiovascular diseases: a US managed care study.
    Foody JM, Joyce AT, Rudolph AE, Liu LZ, Benner JS.
    Curr Med Res Opin; 2008 Jul 01; 24(7):1987-2000. PubMed ID: 18554430
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Use of high potency statins and rates of admission for acute kidney injury: multicenter, retrospective observational analysis of administrative databases.
    Dormuth CR, Hemmelgarn BR, Paterson JM, James MT, Teare GF, Raymond CB, Lafrance JP, Levy A, Garg AX, Ernst P, Canadian Network for Observational Drug Effect Studies.
    BMJ; 2013 Mar 18; 346():f880. PubMed ID: 23511950
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.